Anna Salvetti

3.3k total citations
81 papers, 2.5k citations indexed

About

Anna Salvetti is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Anna Salvetti has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 37 papers in Molecular Biology and 33 papers in Epidemiology. Recurrent topics in Anna Salvetti's work include Virus-based gene therapy research (45 papers), Hepatitis B Virus Studies (15 papers) and Hepatitis C virus research (15 papers). Anna Salvetti is often cited by papers focused on Virus-based gene therapy research (45 papers), Hepatitis B Virus Studies (15 papers) and Hepatitis C virus research (15 papers). Anna Salvetti collaborates with scholars based in France, Germany and United States. Anna Salvetti's co-authors include Philippe Moullier, Gilliane Chadeuf, David Favre, Delphine Bohl, Yan Chérel, Anna Greco, Jean Michel Heard, Véronique Blouin, Karen Nieto and Marie‐Claude Geoffroy and has published in prestigious journals such as Nature Communications, Nano Letters and Blood.

In The Last Decade

Anna Salvetti

79 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Salvetti France 31 1.6k 1.5k 635 422 391 81 2.5k
Stephen R. Yant United States 30 2.7k 1.7× 1.8k 1.2× 423 0.7× 356 0.8× 829 2.1× 47 3.8k
Philip Ng United States 37 2.6k 1.6× 2.5k 1.7× 394 0.6× 750 1.8× 542 1.4× 94 3.8k
J K Yee United States 16 1.8k 1.1× 1.6k 1.1× 449 0.7× 308 0.7× 366 0.9× 19 2.7k
Daniel J. Hui United States 19 1.9k 1.2× 1.7k 1.2× 353 0.6× 766 1.8× 310 0.8× 30 2.8k
Andrew J. Bett United States 26 1.9k 1.2× 1.5k 1.0× 464 0.7× 657 1.6× 746 1.9× 46 3.3k
Atze T. Das Netherlands 30 2.8k 1.7× 627 0.4× 405 0.6× 171 0.4× 765 2.0× 113 3.8k
Julie Johnston United States 17 1.6k 1.0× 1.7k 1.2× 326 0.5× 398 0.9× 323 0.8× 24 2.5k
Anton P. McCaffrey United States 24 3.2k 1.9× 625 0.4× 411 0.6× 152 0.4× 209 0.5× 34 3.9k
Andrew P. Byrnes United States 26 1.3k 0.8× 1.6k 1.1× 391 0.6× 435 1.0× 528 1.4× 45 2.4k
Philippe Mangeot France 20 1.3k 0.8× 501 0.3× 579 0.9× 171 0.4× 196 0.5× 52 2.1k

Countries citing papers authored by Anna Salvetti

Since Specialization
Citations

This map shows the geographic impact of Anna Salvetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Salvetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Salvetti more than expected).

Fields of papers citing papers by Anna Salvetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Salvetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Salvetti. The network helps show where Anna Salvetti may publish in the future.

Co-authorship network of co-authors of Anna Salvetti

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Salvetti. A scholar is included among the top collaborators of Anna Salvetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Salvetti. Anna Salvetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Socol, Marius, Marylène Mougel, Anna Salvetti, et al.. (2024). Soft jamming of viral particles in nanopores. Nature Communications. 15(1). 6180–6180. 2 indexed citations
2.
Vona, Chiara Di, Michel Rivoire, Benoı̂t Chabot, et al.. (2024). The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA. PLoS ONE. 19(10). e0311655–e0311655. 2 indexed citations
3.
Shkreta, Lulzim, Johanne Toutant, David Durantel, et al.. (2024). The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response. Oncotarget. 15(1). 313–325. 2 indexed citations
4.
Mathé, Jérôme, Sha Li, Pascal Martin, et al.. (2023). Thermally Switchable Nanogate Based on Polymer Phase Transition. Nano Letters. 23(11). 4862–4869. 7 indexed citations
5.
Verrier, Éloi R., Anna Salvetti, Caroline Pons, et al.. (2022). Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method. univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg). 12 indexed citations
6.
Socol, Marius, et al.. (2022). Optical Quantification by Nanopores of Viruses, Extracellular Vesicles, and Nanoparticles. Nano Letters. 22(9). 3651–3658. 9 indexed citations
7.
Shkreta, Lulzim, et al.. (2021). SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication. RNA. 27(11). 1302–1317. 18 indexed citations
8.
Lucifora, Julie, Caroline Pons, Floriane Fusil, et al.. (2021). Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production. JHEP Reports. 3(5). 100330–100330. 20 indexed citations
9.
Rossi, Axel, Nadja Meumann, Kathleen A. Christie, et al.. (2019). Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells. Human Gene Therapy. 30(10). 1284–1296. 22 indexed citations
10.
Lucifora, Julie, et al.. (2018). La protéine ISG20, un nouveau facteur de restriction contre le virus de l’hépatite B ?. médecine/sciences. 34(5). 388–391. 1 indexed citations
11.
Nguyen, Xuan-Nhi, Grégory Berger, Andrea Cimarelli, et al.. (2015). Impact of the MRN Complex on Adeno-Associated Virus Integration and Replication during Coinfection with Herpes Simplex Virus 1. Journal of Virology. 89(13). 6824–6834. 12 indexed citations
12.
Ploquin, Aurélie, Judit Szécsi, Cyrille Mathieu, et al.. (2012). Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus–Vector Vaccines. The Journal of Infectious Diseases. 207(3). 469–478. 79 indexed citations
13.
Alazard-Dany, Nathalie, Armel Nicolas, Aurélie Ploquin, et al.. (2009). Definition of Herpes Simplex Virus Type 1 Helper Activities for Adeno-Associated Virus Early Replication Events. PLoS Pathogens. 5(3). e1000340–e1000340. 42 indexed citations
14.
François, Achille, et al.. (2005). Intracellular route and biological activity of exogenously delivered Rep proteins from the adeno-associated virus type 2. Virology. 335(2). 252–263. 6 indexed citations
15.
Geoffroy, Marie‐Claude & Anna Salvetti. (2005). Helper Functions Required for Wild Type and Recombinant Adeno- Associated Virus Growth. Current Gene Therapy. 5(3). 265–271. 63 indexed citations
16.
Blouin, Véronique, et al.. (2004). Improving rAAV production and purification: towards the definition of a scaleable process. The Journal of Gene Medicine. 6(S1). S223–S228. 42 indexed citations
17.
Nony, Pascale, Gilliane Chadeuf, Jacques Tessier, Philippe Moullier, & Anna Salvetti. (2002). Evidence for Packaging of rep-cap Sequences into Adeno-Associated Virus (AAV) Type 2 Capsids in the Absence of Inverted Terminal Repeats: a Model for Generation of rep -Positive AAV Particles. Journal of Virology. 77(1). 776–781. 38 indexed citations
18.
19.
Moullier, Philippe, et al.. (1996). Thérapie génique des maladies lysosomales. Archives de Pédiatrie. 3. S65–S68.
20.
Salvetti, Anna, Alain Lilienbaum, Zhenlin Li, Denise Paulin, & Louis Gazzolo. (1993). Identification of a Negative Element in the Human Vimentin Promoter: Modulation by the Human T-Cell Leukemia Virus Type I Tax Protein. Molecular and Cellular Biology. 13(1). 89–97. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen R. Yant Breakdown of academic impact, for papers by Philip Ng Breakdown of academic impact, for papers by J K Yee Breakdown of academic impact, for papers by Daniel J. Hui Breakdown of academic impact, for papers by Andrew J. Bett Breakdown of academic impact, for papers by Atze T. Das Breakdown of academic impact, for papers by Julie Johnston Breakdown of academic impact, for papers by Anton P. McCaffrey Breakdown of academic impact, for papers by Andrew P. Byrnes Breakdown of academic impact, for papers by Philippe Mangeot
Rankless by CCL
2026